Mood stabilizers are a class of psychiatric medications primarily used to treat bipolar disorder by preventing or reducing the severity of mood episodes, including both mania and depression. They work by modulating neurotransmitter activity and neural signaling to create a more stable emotional baseline, preventing the extreme highs and lows that characterize bipolar spectrum conditions.
There are three main categories of mood stabilizers. Lithium remains the gold standard, with the strongest evidence for preventing manic episodes and reducing suicide risk. It requires regular blood monitoring due to its narrow therapeutic window but has an unmatched efficacy profile for classic bipolar I disorder. Anticonvulsants include several medications originally developed for epilepsy that proved effective as mood stabilizers. Lamotrigine (Lamictal) is particularly effective for bipolar depression prevention and is often preferred for bipolar II disorder. Valproate (Depakote) is effective for acute mania and mixed episodes. Carbamazepine (Tegretol) is used when other options are insufficient. Atypical antipsychotics are increasingly used as mood stabilizers. Quetiapine (Seroquel) treats both mania and bipolar depression. Aripiprazole (Abilify) is effective for manic episodes with a more favorable metabolic profile. Olanzapine and cariprazine also have mood-stabilizing indications.
The choice of mood stabilizer depends on several factors. The type of bipolar disorder matters: lithium and valproate are preferred for bipolar I (prominent mania), while lamotrigine is often first-line for bipolar II (prominent depression). The phase of illness influences selection: some medications are better for acute episodes, others for prevention. Side effect tolerance varies: weight gain concerns may favor lamotrigine or aripiprazole, while sedation needs may favor quetiapine. Reproductive planning is relevant because some mood stabilizers (valproate, carbamazepine) carry significant teratogenic risk. A comprehensive psychiatric evaluation maps the specific pattern of your mood episodes to guide the optimal choice.
No. Antidepressants used alone in bipolar disorder can trigger mania, rapid cycling, or mixed episodes. This is one of the most important reasons accurate diagnosis matters. If you have been diagnosed with depression but experience periods of elevated energy, decreased need for sleep, impulsive behavior, or grandiosity, bipolar disorder should be evaluated before continuing antidepressant monotherapy. When antidepressants are used in bipolar disorder, they are always combined with a mood stabilizer.
Some adults report emotional blunting on mood stabilizers, but this is not universal and is often manageable. The goal of treatment is to reduce extreme highs and lows while preserving normal emotional range. If you feel excessively flat, a dose adjustment or medication switch may help. Lamotrigine is generally considered the least emotionally blunting option.
Bipolar disorder is typically a lifelong condition, and most guidelines recommend long-term or indefinite mood stabilizer treatment after two or more mood episodes. The risk of relapse after stopping is high, with most recurrences happening within 1-2 years of discontinuation. Any decision to taper should be made carefully with your psychiatrist.
Mood stabilizers play a critical role in treating schizoaffective disorder, where mood episodes and psychotic symptoms co-occur.
This content is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment. If you have questions about mood stabilizers, schedule an appointment with Elevate Psychiatry. We serve adults 18 and older through our Miami offices in Coconut Grove and Doral, as well as virtually throughout Florida.
